L. Gérinière

640 total citations
37 papers, 397 citations indexed

About

L. Gérinière is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, L. Gérinière has authored 37 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in L. Gérinière's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Research Studies (9 papers). L. Gérinière is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Research Studies (9 papers). L. Gérinière collaborates with scholars based in France and United States. L. Gérinière's co-authors include H. Bérard, C. Chouaïd, Pierre-Jean Souquet, I. Monnet, H. Le Caer, C. Decroisette, P.-J. Souquet, Gilles Quéré, Clarisse Audigier-Valette and Jean-Marc Vernejoux and has published in prestigious journals such as Annals of Oncology, The Annals of Thoracic Surgery and Journal of Thoracic Oncology.

In The Last Decade

L. Gérinière

33 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Gérinière France 11 228 221 82 60 29 37 397
Uğur Yılmaz Türkiye 12 157 0.7× 123 0.6× 103 1.3× 62 1.0× 39 1.3× 37 353
Jun Kang China 12 184 0.8× 185 0.8× 137 1.7× 73 1.2× 10 0.3× 26 494
P. Hulse United Kingdom 9 135 0.6× 201 0.9× 99 1.2× 118 2.0× 19 0.7× 18 358
Maryam Kadivar Iran 12 91 0.4× 121 0.5× 100 1.2× 42 0.7× 16 0.6× 40 341
Penny Shaw United Kingdom 8 185 0.8× 57 0.3× 48 0.6× 38 0.6× 38 1.3× 12 312
Satoshi Koezuka Japan 9 150 0.7× 80 0.4× 66 0.8× 88 1.5× 18 0.6× 46 271
Valerio Annessi Italy 9 139 0.6× 180 0.8× 79 1.0× 106 1.8× 7 0.2× 21 337
Takashi Ibe Japan 14 290 1.3× 99 0.4× 203 2.5× 39 0.7× 23 0.8× 71 474
F Cameron Australia 9 194 0.9× 110 0.5× 82 1.0× 68 1.1× 116 4.0× 17 413
Hasmukh J. Prajapati United States 11 147 0.6× 87 0.4× 160 2.0× 89 1.5× 45 1.6× 23 414

Countries citing papers authored by L. Gérinière

Since Specialization
Citations

This map shows the geographic impact of L. Gérinière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Gérinière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Gérinière more than expected).

Fields of papers citing papers by L. Gérinière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Gérinière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Gérinière. The network helps show where L. Gérinière may publish in the future.

Co-authorship network of co-authors of L. Gérinière

This figure shows the co-authorship network connecting the top 25 collaborators of L. Gérinière. A scholar is included among the top collaborators of L. Gérinière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Gérinière. L. Gérinière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freymond, N., Florent Wallet, Thomas Gilbert, et al.. (2023). High flow nasal oxygen in frail COVID-19 patients hospitalized in intermediate care units and non-eligible to invasive mechanical ventilation. Respiratory Medicine and Research. 84. 101026–101026. 1 indexed citations
2.
3.
4.
Auliac, J.B., M. Pérol, David Planchard, et al.. (2018). P1.13-09 Efficacy and Tolerance of Osimertinib in Real Word Setting: Results of the French Early Access Program (EXPLORE T790M GFPC Study). Journal of Thoracic Oncology. 13(10). S585–S585. 1 indexed citations
5.
Auliac, J.B., M. Pérol, David Planchard, et al.. (2018). Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation. Lung Cancer. 127. 96–102. 31 indexed citations
6.
7.
Avrillon, Virginie, M. Locatelli-Sanchez, Laure Folliet, et al.. (2015). Lung Cancer May Increase Serum Procalcitonin Level. Infectious Disorders - Drug Targets. 15(1). 57–63. 33 indexed citations
8.
9.
Tissot, Claire, S. Couraud, Philippe Girard, et al.. (2012). Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn's disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis. Journal of Crohn s and Colitis. 6(9). 946–949. 7 indexed citations
10.
Prost, C., S. Couraud, G. Carret, et al.. (2012). Aspergillose pulmonaire chronique nécrosante compliquant une pneumopathie à Mycobacterium malmoense. Revue des Maladies Respiratoires. 29(3). 435–439. 1 indexed citations
11.
Descourt, R., A. Vergnenègre, Fabrice Barlési, et al.. (2010). Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced Non-small Cell Lung Cancer: The GFPC 05-03 Study. Journal of Thoracic Oncology. 6(2). 351–357. 18 indexed citations
12.
Péron, Julien, et al.. (2009). Pleurésie exsudative révélant un anévrisme infectieux de l’aorte abdominale. Revue des Maladies Respiratoires. 27(1). 67–71.
13.
Houot, Roch, et al.. (2008). Tumeurs épithéliales thymiques, neutropénie et anémie hémolytique auto-immunes. Revue des Maladies Respiratoires. 25(5). 605–609. 3 indexed citations
14.
Couraud, S., et al.. (2007). Opacités pulmonaires multiples excavées chez une laborantine de virologie. Revue des Maladies Respiratoires. 24(3). 371–373. 1 indexed citations
15.
16.
Cortot, Alexis B., L. Gérinière, G. Robinet, et al.. (2006). Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study. Annals of Oncology. 17(9). 1412–1417. 35 indexed citations
17.
Girard, Nicolas, et al.. (2004). Expérience française du géfitinib dans le cancer bronchique non à petites cellules. Revue des Maladies Respiratoires. 21(5). 934–942. 1 indexed citations
18.
Khouatra, C., et al.. (2002). Rhabdomyosarcoma arising in mediastinal teratoma in anadult man: a case report. Annals of Oncology. 13(2). 323–326. 8 indexed citations
19.
Khouatra, C., Jérôme Honnorat, P. Bombaron, et al.. (1997). Pseudo-occlusion intestinale et neuronopathie sensitive paranéoplasiques révélatrices d'un cancer bronchique à petites cellules. La Revue de Médecine Interne. 18(8). 652–656. 7 indexed citations
20.
Souquet, P.-J., et al.. (1996). [Spontaneous hydro-pneumothorax disclosing malignant mesothelioma. Apropos of 2 cases].. PubMed. 52(1). 42–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uğur Yılmaz Breakdown of academic impact, for papers by Jun Kang Breakdown of academic impact, for papers by P. Hulse Breakdown of academic impact, for papers by Maryam Kadivar Breakdown of academic impact, for papers by Penny Shaw Breakdown of academic impact, for papers by Satoshi Koezuka Breakdown of academic impact, for papers by Valerio Annessi Breakdown of academic impact, for papers by Takashi Ibe Breakdown of academic impact, for papers by F Cameron Breakdown of academic impact, for papers by Hasmukh J. Prajapati
Rankless by CCL
2026